SCHEMBL18937375

SCHEMBL18937375

O=C(Nc1nn(Cc2ccc(CF)cc2)c2ccccc12)c1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FSCN1 Q16658 1/20 0.55
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 4/20 0.45
TSHR P16473 2/20 0.45
CASP1 P29466 2/20 0.45
CASP7 P55210 2/20 0.45
HSD17B10 Q99714 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
RAB9A P51151 1/20 0.45
USP2 O75604 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PTGER4 P35408 4/20 0.43
GAA P10253 1/20 0.43
THRB P10828 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17039003 0.88 FSCN1 (0.71) FSCN1KDM4EALDH1A1HPGDTSHR
SCHEMBL30695063 0.88 FSCN1 (0.71) FSCN1KDM4EALDH1A1HPGDTSHR
SCHEMBL17199364 0.88 FSCN1 (0.52) FSCN1PTGER4PTGS1PTGS2HDAC1
SCHEMBL17199318 0.87 FSCN1 (0.54) FSCN1PTGER4PTGS1PTGS2HDAC1
SCHEMBL17199347 0.86 FSCN1 (0.60) FSCN1RAB9APTGER4SMN1; SMN2HDAC1
SCHEMBL17199344 0.86 FSCN1 (0.52) FSCN1KDM4EALDH1A1HPGDTSHR
SCHEMBL17199362 0.84 FSCN1 (0.56) FSCN1PTGER4MAPTHDAC1HDAC10
SCHEMBL17199346 0.84 FSCN1 (0.58) FSCN1PTGER4PTGS1PTGS2HDAC1
SCHEMBL17199354 0.84 FSCN1 (0.53) FSCN1PTGER4MAPTHDAC1HDAC10
SCHEMBL18937571 0.84 FSCN1 (0.52) FSCN1RAB9APTGER4HDAC1HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170158692-A1 COMPOUNDS AND METHODS FOR INHIBITING FASCIN CORNELL UNIVERSITY 2017-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170158692-A1 COMPOUNDS AND METHODS FOR INHIBITING FASCIN FSCN1, MTPN, MYOF FSCN1 1/4885KDM4E 4674/4885ALDH1A1 3976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.